Yifeng Pharmacy Chain Co., Ltd. (603939.SS)
CNY 25.67
(-0.62%)
CNY 25.67
(-0.62%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 10.05 Billion CNY | 190.82% |
| 2022 | 3.45 Billion CNY | 3.97% |
| 2021 | 3.32 Billion CNY | 37.66% |
| 2020 | 2.41 Billion CNY | 211.55% |
| 2019 | 775.35 Million CNY | -1.73% |
| 2018 | 789 Million CNY | -14.26% |
| 2017 | 920.22 Million CNY | 23.51% |
| 2016 | 745.04 Million CNY | 23.12% |
| 2015 | 605.14 Million CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | -100.0% |
| 2011 | 27 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 8.03 Billion CNY | -65.27% |
| 2024 Q1 | 11.12 Billion CNY | 10.6% |
| 2024 Q2 | 11.44 Billion CNY | 2.9% |
| 2023 Q3 | 3.58 Billion CNY | 2.13% |
| 2023 Q4 | 10.05 Billion CNY | 180.55% |
| 2023 FY | 10.05 Billion CNY | 190.82% |
| 2023 Q1 | 3.48 Billion CNY | 0.84% |
| 2023 Q2 | 3.5 Billion CNY | 0.65% |
| 2022 Q4 | 3.45 Billion CNY | -10.62% |
| 2022 Q3 | 3.86 Billion CNY | 13.68% |
| 2022 Q1 | 3.41 Billion CNY | 2.78% |
| 2022 Q2 | 3.4 Billion CNY | -0.43% |
| 2022 FY | 3.45 Billion CNY | 3.97% |
| 2021 Q1 | 3.48 Billion CNY | 44.39% |
| 2021 Q4 | 3.32 Billion CNY | 3.35% |
| 2021 Q3 | 3.21 Billion CNY | -9.03% |
| 2021 FY | 3.32 Billion CNY | 37.66% |
| 2021 Q2 | 3.53 Billion CNY | 1.41% |
| 2020 Q1 | 1.15 Billion CNY | 48.51% |
| 2020 FY | 2.41 Billion CNY | 211.55% |
| 2020 Q3 | 2.42 Billion CNY | -2.39% |
| 2020 Q4 | 2.41 Billion CNY | -0.57% |
| 2020 Q2 | 2.48 Billion CNY | 116.16% |
| 2019 FY | 775.35 Million CNY | -1.73% |
| 2019 Q4 | 775.35 Million CNY | 0.72% |
| 2019 Q3 | 769.8 Million CNY | -5.31% |
| 2019 Q2 | 813 Million CNY | -0.25% |
| 2019 Q1 | 815 Million CNY | 3.3% |
| 2018 Q2 | 13 Million CNY | 0.0% |
| 2018 Q4 | 789 Million CNY | 140.92% |
| 2018 Q3 | 327.5 Million CNY | 2419.23% |
| 2018 Q1 | 13 Million CNY | 0.0% |
| 2018 FY | 789 Million CNY | -14.26% |
| 2017 Q1 | - CNY | 0.0% |
| 2017 FY | 920.22 Million CNY | 23.51% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 Q3 | - CNY | 0.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2016 Q3 | - CNY | 0.0% |
| 2016 Q2 | - CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 FY | 745.04 Million CNY | 23.12% |
| 2016 Q4 | - CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 Q4 | - CNY | 0.0% |
| 2015 Q3 | - CNY | 0.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2015 FY | 605.14 Million CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2012 FY | - CNY | -100.0% |
| 2011 FY | 27 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Shanghai No.1 Pharmacy Co., Ltd. | 326.9 Million CNY | -2975.816% |
| Jointown Pharmaceutical Group Co., Ltd | 38.76 Billion CNY | 74.063% |
| LBX Pharmacy Chain Joint Stock Company | 9.86 Billion CNY | -1.956% |
| Yunnan Jianzhijia Health-Chain Co., Ltd. | 3.69 Billion CNY | -172.059% |